Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal counsel to Aadi. McDermott Will & Emery LLP is serving as legal counsel to Kaken. Cooley...
Aadi Bioscience’s $849 Million ADC Deal, $100 Million FYARRO Sale and $100 Million PIPE Financing
Illumina’s Acquisition of Fluent BioSciences
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
Marengo Therapeutics’ Expansion of Research Partnership with Ipsen
Wilson Sonsini Goodrich & Rosati advised Marengo Therapeutics on the transaction. Marengo Therapeutics announced the expansion of their ongoing oncology research partnership to include TriSTAR, Marengo’s...
Gilead’s Acquisition of XinThera
Wilson Sonsini Goodrich & Rosati advised XinThera on the transaction. Gilead Sciences announced the acquisition of San Diego-based XinThera, a privately held biotech company. The acquisition...
Third Rock Ventures’ Investment in CARGO Therapeutics
Orrick advised Third Rock Ventures on the deal while Wilson Sonsini represented CARGO Therapeutics. Third Rock Ventures announced its investment in the $200 million Series A financing...